Pennsylvania Bio Announces the Appointment of Five New Members to its Board of Directors
Oct 5 15
Pennsylvania Bio announced the appointment of five new members to its Board of Directors: The five new members were Brian K. Halak, John Hubbard, David H. Ledbetter, Bruce J. Shook and Bryan Wolf. Dr. Halak is currently a member of the Advisory Board for the Department of BioEngineering of the University of Pennsylvania and serves as an advisor to Elm Street Ventures. Prior to joining the company, Dr. Hubbard was Senior Vice President and Worldwide Head of Development Operations for Pfizer. Bruce Shook is the President and CEO of Intact Vascular Inc. in Wayne, PA. Mr. Shook currently serves as a Director on the Boards of Surgiquest Inc. (Milford, CT). In 2015, Dr. Wolf was appointed Chief Scientific Officer and Executive Vice President at The Children’s Hospital of Philadelphia (CHOP) and Director of the CHOP Research Institute.
Egalet Corporation Announces Bob Radie to Be Pennsylvania Bio Board of Directors
May 12 15
Egalet Corporation announced Bob Radie, Egalet's president and chief executive officer (CEO), has been appointed to the Pennsylvania Bio board of directors. Mr. Radie is one of nine new directors. Mr. Radie has been president, CEO and director of Egalet since March 2012. From November 2010 to October 2011, Mr. Radie served as president and CEO of Topaz Pharmaceuticals Inc. From March 2009 to November 2010, Mr. Radie served as president and CEO of Transmolecular Inc., after serving as a consultant to Transmolecular from December 2008 through March 2009.
Pennsylvania Bio Announces Board Changes
May 11 15
Pennsylvania Bio announced the appointment of Marc S. Malandro, PhD, CLP, RTTP as chairman-elect of the association. Dr. Malandro is the Founding Director of the University of Pittsburgh’s Innovation Institute and Associate Vice Chancellor for Technology Management and Commercialization at the University of Pittsburgh. He will assume the position of chairman at the January 2016 meeting of the Pennsylvania Bio Board of Directors. The association also announced the election of nine new members to its Board of Directors: Neil J. Campbell, President, CEO and Founder, Helomics Corporation; Christopher M. Cashman, President and CEO, Marinus Pharmaceuticals; Glen N. Gaulton, Ph.D., Executive Vice Dean and Chief Scientific Officer, Perelman School of Medicine, University of Pennsylvania; Maxine Gowen, Ph.D., President and CEO, Trevena; Mahmood Ladha, VP, US Business Development Operations, Head of Transactions, AstraZeneca; Terri J. Lee, Vice President, State Government Affairs & Policy, Merck; Christian Manders, Chief Operating Officer, Promethean LifeSciences Inc.; Robert Radie, President and Chief Executive Officer, Egalet Corporation; Dr. Neal Walker, President and CEO, Aclaris Therapeutics. Neil Campbell is currently the President, CEO and Founder of Helomics. Chris Cashmanis President and CEO of Marinus and also serves as Chairman of the Marinus Board of Directors. Glen N. Gaulton, Ph.D. is the Executive Vice Dean and Chief Scientific Officer, and Professor of Pathology and Laboratory of Medicine at the University of Pennsylvania’s Perelman School of Medicine. Dr. Maxine Gowen is the founding President and CEO of Trevena. Terri Lee is Vice President of State Government Affairs and Policy for Merck & Co. Inc. Christian Manders is the Chief Operating Officer of Promethean Life Sciences. Robert Radieis President and CEO and a member of the Board of Directors at Egalet Corporation. Dr. Neal Walker is co-founder, President and Chief Executive Officer at Aclaris Therapeutics Inc.